Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Tianjin Medical University Cancer Institute and Hospital)"
Count: 258
Selected: 0
NCT IDTitle
NCT03367884Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal Cancer
NCT03358602Radiotherapy vs Neck Dissection for Clinical T1/2N0 Supraglottic Cancer
NCT05273827Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium
NCT03708042A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer
NCT02765620PERCIST Criteria for Response Evaluation With Solid Tumors
NCT04807673Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)
NCT04079283Radiomics of Immunotherapeutics Response Evaluation and Prediction
NCT04900311Pyrotinib Versus Pertuzumab in Combination With Neoadjuvant Trastuzumab and Nab-Paclitaxel in HER2+ Early or Locally Advanced Breast Cancer
NCT04843215A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer
NCT03992833Methods of Computed Tomography Screening and Management of Lung Cancer
NCT02272894A Trial to Evaluate the Superior Mesenteric Vein (14V) Lymphadenectomy for Distal Advanced Gastric Cancer
NCT03121846Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy
NCT03366883Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC
NCT02672488Metformin Plus Sorafenib for Advanced HCC
NCT02615223Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer
NCT02605226Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate Cancer
NCT03861221The Technical Operations And Standard Clinical Application Protocol of CBBCT in Diagnostic Process of Breast Cancer
NCT05356351An Open-label, Single-arm, Multicenter Phase II Clinical Study: Evaluating RC48-ADC Combined With Triplizumab in the Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cancer
NCT03837782Outcome of Resection for Colorectal Cancer
NCT05535647Second Line Therapy for Advanced Intrahepatic Cholangiocarcinoma
NCT05524155Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver Metastasis
NCT05522985Neoadjuvant Chemotherapytreatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT05519410Sintilimab Combined With Lenvatinib Versus HAIC for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma
NCT05507606Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations
NCT05507593Study of DLL3-CAR-NK Cells in the Treatment of Extensive Stage Small Cell Lung Cancer
NCT05490719A Phase II Study of CRT Combined With QL1706 in ESCC Patients
NCT05476380Neoadjuvant Therapy of Camrelizumab Combined With Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
NCT05458180CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma
NCT05449483Conversion of Tislelizumab Combined With Chemotherapy in Unresectable Esophageal Squamous Cell Carcinoma
NCT05392686PD1 and PARP for Maintenance Therapy in NSLLC
NCT05325190Granisetron Transdermal Patch System for Prevention of CINV by CapeOX
NCT05295043A Multicenter Clinical Study Evaluating the Clinical Outcomes of HR+/HER2- Advanced Breast Cancer With Different HER2 Expression Levels in Combination With a Real-world CDK4/6 Inhibitor Combined With Endocrine Therapy
NCT05273814Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer
NCT05263947Bevacizumab Combined With Double Dose Icotinib in Patients With EGFR Exon 21-L858R Mutation
NCT05251662Sintilimab Combined With GEMOX ± IBI305 (Bevacizumab Biosimilar) Versus GEMOX in Advanced Intrahepatic Cholangiocarcinoma
NCT05228743Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric Cancer
NCT05221775Safety of XELOX Combined With GLS-010 and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients
NCT05215665GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma
NCT05199168Visualization Versus Intraoperative Neuromonitoring of the Recurrent Laryngeal Nerves During Thoracoscopic Esophagectomy
NCT05167643H (Trastuzumab or Biosimilar) Combined With CDK4/6 Inhibitor + AI±OFS in the Treatment of HR+HER2+ Advanced Breast Cancer Efficacy and Safety: a Chinese Multi-center Real World Study
NCT05166772Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy,HAIC)in the First-line Treatment of Unresectable Hepatocellular Carcinoma
NCT05085626Fluzoparib in Combination With Chidamide or Camrelizumab for HRD Positive HER2 Negative Advanced Breast Cancer
NCT05084677Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer
NCT05077839Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in mCRC
NCT05076097A Study of OLR in First-line Treatment of Mantle Cell Lymphoma
NCT05036798Tislelizumab+Lenvatinib+Gemox Regiment for Potentially Resectable Locally Advanced Malignant Tumors of Biliary System.
NCT05035381PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal Cancer
NCT05035147Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer
NCT05029973HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Advanced Unresectable HCC
NCT05025033Chemotherapy Combined With Apatinib and PD-1 Antibody